0001209191-24-001165.txt : 20240108 0001209191-24-001165.hdr.sgml : 20240108 20240108165043 ACCESSION NUMBER: 0001209191-24-001165 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240104 FILED AS OF DATE: 20240108 DATE AS OF CHANGE: 20240108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shook David CENTRAL INDEX KEY: 0001959742 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39370 FILM NUMBER: 24520827 MAIL ADDRESS: STREET 1: 6000 SHORELINE COURT, SUITE 102 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nkarta, Inc. CENTRAL INDEX KEY: 0001787400 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 474515206 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1150 VETERANS BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (925) 407-1049 MAIL ADDRESS: STREET 1: 1150 VETERANS BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2024-01-04 0 0001787400 Nkarta, Inc. NKTX 0001959742 Shook David C/O NKARTA, INC. 1150 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Chief Medical Officer 0 Common Stock 2024-01-04 4 A 0 56000 0.00 A 118532 D Stock Option (right to buy) 6.01 2024-01-04 4 A 0 112500 0.00 A 2034-01-03 Common Stock 112500 112500 D Represents Restricted Stock Units ("RSUs") which vest in four equal annual installments beginning on January 14, 2025. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. Includes 2,000 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan on November 30, 2023. This option is scheduled to vest and become exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following January 14, 2024. /s/ Alicia Hager, as Attorney-in-Fact 2024-01-08